drugset / Trial / NCT00232700

Investigation of a Combination Treatment of Escitalopram and rTMS

NCT00232700

RandomizedParallel-groupDouble-blindTreatment

Summary

We intend to test in a randomized, rater blinded, placebo controlled, prospective study the primary hypothesis that an escitalopram-rTMS-combination treatment is more efficacious in the treatment of refractory major depression assessed with the Hamilton Depression Rating Scale

Timeline

Start
2005-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule